Advertisement
Screener

Tyra Biosciences, Inc. (TYRA) Form D

Tyra Biosciences, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-02-13: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2024-02-06; Total offering amount $199,999,934.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-02-13Rule 506(b)Equity; OptionToAcquire2024-02-06$199,999,934$199,999,934$021

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kardigan, Inc. (KARD)United States$1.346B
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Avalyn Pharma Inc. (AVLN)United States$1.267B
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
HARROW, INC. (HROW)United States$1.240B-42.77
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
OMEROS CORP (OMER)United States$1.456B5.50